{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:08:49Z","timestamp":1771546129713,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.exer.2011.11.003","type":"journal-article","created":{"date-parts":[[2011,11,20]],"date-time":"2011-11-20T22:03:41Z","timestamp":1321826621000},"page":"41-48","source":"Crossref","is-referenced-by-count":49,"title":["Inhibition of pathological retinal angiogenesis by the integrin \u03b1v\u03b23 antagonist tetraiodothyroacetic acid (tetrac)"],"prefix":"10.1016","volume":"94","author":[{"given":"Takeshi","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junsong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elia J.","family":"Duh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2011.11.003_bib1","first-page":"36","article-title":"Image processing with imageJ","volume":"11","author":"Abr\u00e0moff","year":"2004","journal-title":"Biophoton. Int."},{"key":"10.1016\/j.exer.2011.11.003_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ophtha.2005.10.012","article-title":"Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals","volume":"113","author":"Adamis","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2011.11.003_bib3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0002-9394(14)75794-0","article-title":"Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy","volume":"118","author":"Adamis","year":"1994","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2011.11.003_bib4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJMe058142","article-title":"Angiogenic pathways in diabetic retinopathy","volume":"353","author":"Aiello","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.exer.2011.11.003_bib5","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.exer.2011.11.003_bib6","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","article-title":"Suppression of retinal neovascularization in\u00a0vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins","volume":"92","author":"Aiello","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.exer.2011.11.003_bib7","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1073\/pnas.87.15.5978","article-title":"Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells","volume":"87","author":"Anagnostou","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1695","key":"10.1016\/j.exer.2011.11.003_bib8","first-page":"e1691","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2011.11.003_bib9","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1210\/en.2005-0102","article-title":"Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis","volume":"146","author":"Bergh","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.exer.2011.11.003_bib10","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/0092-8674(94)90007-8","article-title":"Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels","volume":"79","author":"Brooks","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.exer.2011.11.003_bib11","article-title":"Erythropoietin siRNA suppresses retinal neovascularization in a mouse model of proliferative retinopathy","author":"Chen","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2011.11.003_bib12","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nprot.2009.187","article-title":"Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis","volume":"4","author":"Connor","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.exer.2011.11.003_bib13","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/01.RES.0000130784.90237.4a","article-title":"Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface","volume":"94","author":"Davis","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.exer.2011.11.003_bib14","first-page":"821","article-title":"Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth","volume":"43","author":"Duh","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2011.11.003_bib15","doi-asserted-by":"crossref","first-page":"9764","DOI":"10.1073\/pnas.93.18.9764","article-title":"Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases","volume":"93","author":"Friedlander","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.exer.2011.11.003_bib16","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.4161\/cc.8.21.9963","article-title":"Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac)","volume":"8","author":"Glinskii","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.exer.2011.11.003_bib17","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1091\/mbc.E04-11-1029","article-title":"Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells","volume":"16","author":"Im","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.exer.2011.11.003_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/08820530902800330","article-title":"Review of anti-VEGF therapy in proliferative diabetic retinopathy","volume":"24","author":"Jardeleza","year":"2009","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.exer.2011.11.003_bib19","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.2337\/diacare.28.9.2252","article-title":"Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy","volume":"28","author":"Katsura","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.exer.2011.11.003_bib20","first-page":"563","article-title":"Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine model","volume":"75","author":"Luna","year":"1996","journal-title":"Lab. Invest."},{"key":"10.1016\/j.exer.2011.11.003_bib21","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1167\/iovs.08-1760","article-title":"Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells","volume":"49","author":"Maiti","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2011.11.003_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10456-007-9088-7","article-title":"Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor","volume":"11","author":"Mousa","year":"2008","journal-title":"Angiogenesis"},{"key":"10.1016\/j.exer.2011.11.003_bib23","first-page":"407","article-title":"Pro-angiogenesis action of thyroid hormone and analogs in a three-dimensional in\u00a0vitro microvascular endothelial sprouting model","volume":"25","author":"Mousa","year":"2006","journal-title":"Int. Angiol."},{"key":"10.1016\/j.exer.2011.11.003_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2353\/ajpath.2006.050435","article-title":"EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown","volume":"168","author":"Ojima","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2011.11.003_bib25","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood.V93.8.2627","article-title":"Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in\u00a0vivo","volume":"93","author":"Ribatti","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exer.2011.11.003_bib26","first-page":"3475","article-title":"Immunolocalization of integrins in proliferative retinal membranes","volume":"35","author":"Robbins","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2011.11.003_bib27","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2011.11.003_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12013-008-9040-5","article-title":"Integrin and growth factor receptor alliance in angiogenesis","volume":"53","author":"Somanath","year":"2009","journal-title":"Cell. Biochem. Biophys."},{"key":"10.1016\/j.exer.2011.11.003_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10456-009-9141-9","article-title":"Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis","volume":"12","author":"Somanath","year":"2009","journal-title":"Angiogenesis"},{"key":"10.1016\/j.exer.2011.11.003_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0070-2153(04)64009-9","article-title":"Integrins and angiogenesis","volume":"64","author":"Stupack","year":"2004","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.exer.2011.11.003_bib31","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1073\/pnas.0800454105","article-title":"Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications","volume":"105","author":"Tong","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.exer.2011.11.003_bib32","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJMoa041773","article-title":"Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy","volume":"353","author":"Watanabe","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.exer.2011.11.003_bib33","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1161\/01.ATV.0000248731.55781.87","article-title":"Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells","volume":"26","author":"Xu","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.exer.2011.11.003_bib34","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1167\/iovs.05-1528","article-title":"Vascular endothelial growth factor upregulates expression of ADAMTS1 in endothelial cells through protein kinase C signaling","volume":"47","author":"Xu","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2011.11.003_bib35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/thy.2009.0249","article-title":"Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma","volume":"20","author":"Yalcin","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.exer.2011.11.003_bib36","first-page":"3825","article-title":"Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts","volume":"29","author":"Yalcin","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.exer.2011.11.003_bib37","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1210\/jc.2009-1926","article-title":"Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid","volume":"95","author":"Yalcin","year":"2010","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.exer.2011.11.003_bib38","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1042\/bst0311171","article-title":"VEGF signalling: integration and multi-tasking in endothelial cell biology","volume":"31","author":"Zachary","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.exer.2011.11.003_bib39","doi-asserted-by":"crossref","first-page":"H2467","DOI":"10.1152\/ajpheart.00649.2006","article-title":"Erythropoietin promotes survival of primary human endothelial cells through PI3K-dependent, NF-kappaB-independent upregulation of Bcl-xL","volume":"292","author":"Zhande","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483511003599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483511003599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T19:53:02Z","timestamp":1593287582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483511003599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0014483511003599"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2011.11.003","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}